Stock data

MaxCyte, Inc. (MXCT)

MaxCyte, Inc. (MXCT) reported revenue of US$20.96M and net income of -US$44.63M for fiscal 2025. The figures below come from the company's SEC filings.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open MaxCyte, Inc. in Insightr